Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

In this episode, Contributing Editor Kate Markey, MBBS, PhD, talks with Shernan Holtan, MD, one of the authors of a paper published recently in The New England Journal of Medicine: “Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis.”

Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/

What is The Hematologist?

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.